Login
Toggle sidebar

Lint: who-classification-of-haematolymphoid-tumours

who-classification-of-haematolymphoid-tumours
Units
error

"myelodysplastic neoplasm with low blasts and SF3B1 mutation"

Line 38:57 · Put a space between the number and the unit in 'SF3B1mutation'.

"myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis"

Line 64:61 · Put a space between the number and the unit in 'SF3B1mutation'.
Adjectival Hyphens
error

"pre-neoplastic and neoplastic small lymphocytic proliferations"

Line 212:4 · Only use medical adjectival hyphens where the letters at the end and start of the compound word are the same, e.g. post-transplant. In this case, don't use the hyphen: 'pre-neoplastic'.
Acronyms
warning

"myeloproliferative neoplasm, NOS"

Line 20:40 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"myelodysplastic/myeloproliferative neoplasm, NOS"

Line 65:56 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"acute promyelocytic leukaemia with PML::RARA fusion"

Line 73:55 · 'RARA' has no definition. Spell it out if it's unfamiliar to the audience.

"acute leukaemia of ambiguous lineage, NOS"

Line 138:49 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"ALK-positive histiocytosis"

Line 176:11 · 'ALK' has no definition. Spell it out if it's unfamiliar to the audience.

"KSHV/HHV8-associated multicentric Castleman disease"

Line 187:8 · 'KSHV' has no definition. Spell it out if it's unfamiliar to the audience.

"B-lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion"

Line 204:58 · 'HLF' has no definition. Spell it out if it's unfamiliar to the audience.

"B-lymphoblastic leukaemia/lymphoma, NOS"

Line 206:47 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"diffuse large B-cell lymphoma, NOS"

Line 262:42 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"ALK-positive large B-cell lymphoma"

Line 265:8 · 'ALK' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive diffuse large B-cell lymphoma"

Line 269:11 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"high-grade B-cell lymphoma, NOS"

Line 279:39 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas"

Line 284:4 · 'KSHV' has no definition. Spell it out if it's unfamiliar to the audience.

"KSHV/HHV8-positive diffuse large B-cell lymphoma"

Line 287:8 · 'KSHV' has no definition. Spell it out if it's unfamiliar to the audience.

"KSHV/HHV8-positive germinotropic lymphoproliferative disorder"

Line 288:8 · 'KSHV' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive mucocutaneous ulcer"

Line 296:8 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"immunoglobulin-related (AL) amyloidosis"

Line 321:35 · 'AL' has no definition. Spell it out if it's unfamiliar to the audience.

"T-cell and NK-cell lymphoid proliferations and lymphomas"

Line 342:16 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"T-lymphoblastic leukaemia/lymphoma, NOS"

Line 351:47 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"Mature T-cell and NK-cell neoplasms"

Line 354:23 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"mature T-cell and NK-cell leukaemias"

Line 357:22 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"NK-large granular lymphocytic leukaemia"

Line 361:8 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"aggressive NK-cell leukaemia"

Line 364:19 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"primary cutaneous peripheral T-cell lymphoma, NOS"

Line 378:57 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"intestinal T-cell and NK-cell lymphoid proliferations and lymphomas"

Line 382:26 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract"

Line 385:17 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"intestinal T-cell lymphoma, NOS"

Line 388:39 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"ALK-positive anaplastic large cell lymphoma"

Line 395:8 · 'ALK' has no definition. Spell it out if it's unfamiliar to the audience.

"ALK-negative anaplastic large cell lymphoma"

Line 396:8 · 'ALK' has no definition. Spell it out if it's unfamiliar to the audience.

"nodal TFH cell lymphoma, NOS"

Line 405:33 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"peripheral T-cell lymphoma, NOS"

Line 408:39 · 'NOS' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive NK-cell and T-cell lymphomas"

Line 410:4 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive NK-cell and T-cell lymphomas"

Line 410:17 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive nodal T- and NK-cell lymphoma"

Line 412:8 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive nodal T- and NK-cell lymphoma"

Line 412:34 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"extranodal NK/T-cell lymphoma"

Line 413:19 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood"

Line 417:4 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood"

Line 417:28 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.

"systemic chronic active EBV disease"

Line 421:32 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"systemic EBV-positive T-cell lymphoma of childhood"

Line 422:17 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"EBV-positive inflammatory follicular dendritic cell sarcoma"

Line 430:8 · 'EBV' has no definition. Spell it out if it's unfamiliar to the audience.

"NK-lymphoblastic leukaemia/lymphoma"

Line 455:8 · 'NK' has no definition. Spell it out if it's unfamiliar to the audience.
Emphasis
warning

"myelodysplastic neoplasm with low blasts and SF3B1 mutation"

Line 38:53 · Italics should be used only in exceptional circumstances: '<em>SF3B1 </em>'

"myelodysplastic neoplasm with biallelic TP53 inactivation"

Line 39:48 · Italics should be used only in exceptional circumstances: '<em>TP53 </em>'

"myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis"

Line 64:57 · Italics should be used only in exceptional circumstances: '<em>SF3B1 </em>'

"acute promyelocytic leukaemia with PML::RARA fusion"

Line 73:46 · Italics should be used only in exceptional circumstances: '<em>PML::RARA</em>'

"acute myeloid leukaemia with RUNX1::RUNX1T1 fusion"

Line 74:37 · Italics should be used only in exceptional circumstances: '<em>RUNX1::RUNX1T1</em>'

"acute myeloid leukaemia with CBFB::MYH11 fusion"

Line 75:37 · Italics should be used only in exceptional circumstances: '<em>CBFB::MYH11</em>'

"acute myeloid leukaemia with DEK::NUP214 fusion"

Line 76:37 · Italics should be used only in exceptional circumstances: '<em>DEK::NUP214</em>'

"acute myeloid leukaemia with RBM15::MRTFA fusion"

Line 77:37 · Italics should be used only in exceptional circumstances: '<em>RBM15::MRTFA</em>'

"acute myeloid leukaemia with BCR::ABL1 fusion"

Line 78:37 · Italics should be used only in exceptional circumstances: '<em>BCR::ABL1</em>'

"acute myeloid leukaemia with KMT2A rearrangement"

Line 79:37 · Italics should be used only in exceptional circumstances: '<em>KMT2A</em>'

"acute myeloid leukaemia with MECOM rearrangement"

Line 80:37 · Italics should be used only in exceptional circumstances: '<em>MECOM</em>'

"acute myeloid leukaemia with NUP98 rearrangement"

Line 81:37 · Italics should be used only in exceptional circumstances: '<em>NUP98</em>'

"myeloid/lymphoid neoplasms with PDGFRA rearrangement"

Line 113:40 · Italics should be used only in exceptional circumstances: '<em>PDGFRA </em>'

"myeloid/lymphoid neoplasms with PDGFRB rearrangement"

Line 114:40 · Italics should be used only in exceptional circumstances: '<em>PDGFRB </em>'

"myeloid/lymphoid neoplasms with FGFR1 rearrangement"

Line 115:40 · Italics should be used only in exceptional circumstances: '<em>FGFR1 </em>'

"myeloid/lymphoid neoplasms with JAK2 rearrangement"

Line 116:40 · Italics should be used only in exceptional circumstances: '<em>JAK2 </em>'

"myeloid/lymphoid neoplasm with FLT3 rearrangement"

Line 117:39 · Italics should be used only in exceptional circumstances: '<em>FLT3</em>'

"myeloid/lymphoid neoplasm with ETV6::ABL1 fusion"

Line 118:39 · Italics should be used only in exceptional circumstances: '<em>ETV6::ABL1</em>'

"mixed-phenotype acute leukaemia with BCR::ABL1 fusion"

Line 127:45 · Italics should be used only in exceptional circumstances: '<em>BCR::ABL1</em>'

"mixed-phenotype acute leukaemia with KMT2A rearrangement"

Line 128:45 · Italics should be used only in exceptional circumstances: '<em>KMT2A </em>'

"B-lymphoblastic leukaemia/lymphoma with iAMP21"

Line 196:48 · Italics should be used only in exceptional circumstances: '<em>iAMP21</em>'

"B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion"

Line 197:48 · Italics should be used only in exceptional circumstances: '<em>BCR::ABL1</em>'

"B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features"

Line 198:48 · Italics should be used only in exceptional circumstances: '<em>BCR::ABL1-like</em>'

"B-lymphoblastic leukaemia/lymphoma with KMT2A rearrangement"

Line 199:48 · Italics should be used only in exceptional circumstances: '<em>KMT2A</em>'

"B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion"

Line 200:48 · Italics should be used only in exceptional circumstances: '<em>ETV6::RUNX1</em>'

"B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features"

Line 201:48 · Italics should be used only in exceptional circumstances: '<em>ETV6::RUNX1-like</em>'

"B-lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion"

Line 202:48 · Italics should be used only in exceptional circumstances: '<em>TCF3::PBX1</em>'

"B-lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion"

Line 203:47 · Italics should be used only in exceptional circumstances: '<em> IGH::IL3 </em>'

"B-lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion"

Line 204:48 · Italics should be used only in exceptional circumstances: '<em>TCF3::HLF</em>'

"diffuse large B-cell lymphoma / high-grade B-cell lymphoma with MYC and BCL2 rearrangements"

Line 264:72 · Italics should be used only in exceptional circumstances: '<em>MYC </em>and <em>BCL2</em>'

"large B-cell lymphoma with IRF4 rearrangement"

Line 266:35 · Italics should be used only in exceptional circumstances: '<em>IRF4</em>'
List Caps
warning

"Langerhans cells neoplasms"

Line 155:4 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Langerhans cell histiocytosis"

Line 157:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Langerhans cell sarcoma"

Line 158:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Rosai-Dorfman Disease"

Line 175:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Burkitt lymphoma"

Line 282:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"IgM monoclonal gammopathy of undetermined significance"

Line 313:8 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Fanconi anaemia"

Line 443:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
Headings Case
warning

"Precursor B-cell neoplasms"

Line 189:5 · 'Precursor B-cell neoplasms' should use sentence-style capitalization.

"Mature B-cell neoplasms"

Line 209:5 · 'Mature B-cell neoplasms' should use sentence-style capitalization.

"Precursor T-cell neoplasms"

Line 349:5 · 'Precursor T-cell neoplasms' should use sentence-style capitalization.

"Mature T-cell and NK-cell neoplasms"

Line 354:5 · 'Mature T-cell and NK-cell neoplasms' should use sentence-style capitalization.
Headings Valid
warning

Expected headings

  • H1 Usage
  • H1 Classification
  • H1 History and etymology
  • H1 Related pathology
  • H1 See also

"Myeloid proliferations and neoplasms"

Line 3:1 · "Myeloid proliferations and neoplasms" is not a recognised heading for this article type.

"Myeloid precursor lesion"

Line 4:1 · "Myeloid precursor lesion" is not a recognised heading for this article type.

"Myeloproliferative neoplasms"

Line 9:1 · "Myeloproliferative neoplasms" is not a recognised heading for this article type.

"Mastocytosis"

Line 23:1 · "Mastocytosis" is not a recognised heading for this article type.

"Myelodysplastic neoplasms"

Line 32:1 · "Myelodysplastic neoplasms" is not a recognised heading for this article type.

"Myelodysplastic/myeloproliferative neoplasms"

Line 58:1 · "Myelodysplastic/myeloproliferative neoplasms" is not a recognised heading for this article type.

"Acute myeloid leukaemia"

Line 68:1 · "Acute myeloid leukaemia" is not a recognised heading for this article type.

"Myeloid neoplasms, secondary"

Line 103:1 · "Myeloid neoplasms, secondary" is not a recognised heading for this article type.

"Myeloid/lymphoid neoplasms"

Line 109:1 · "Myeloid/lymphoid neoplasms" is not a recognised heading for this article type.

"Acute leukaemias of mixed or ambiguous lineage"

Line 122:1 · "Acute leukaemias of mixed or ambiguous lineage" is not a recognised heading for this article type.

"Histiocytic / dendritic cell neoplasms"

Line 143:1 · "Histiocytic / dendritic cell neoplasms" is not a recognised heading for this article type.

"Plasmacytoid dendritic cell neoplasms"

Line 144:1 · "Plasmacytoid dendritic cell neoplasms" is not a recognised heading for this article type.

"Langerhans cell and other dendritic cell neoplasms"

Line 152:1 · "Langerhans cell and other dendritic cell neoplasms" is not a recognised heading for this article type.

"Histiocyte/macrophage neoplasms"

Line 169:1 · "Histiocyte/macrophage neoplasms" is not a recognised heading for this article type.

"B-cell lymphoid proliferations and lymphomas"

Line 180:1 · "B-cell lymphoid proliferations and lymphomas" is not a recognised heading for this article type.

"Tumour-like lesions with B-cell predominance"

Line 181:1 · "Tumour-like lesions with B-cell predominance" is not a recognised heading for this article type.

"Precursor B-cell neoplasms"

Line 189:1 · "Precursor B-cell neoplasms" is not a recognised heading for this article type.

"Mature B-cell neoplasms"

Line 209:1 · "Mature B-cell neoplasms" is not a recognised heading for this article type.

"Hodgkin lymphoma"

Line 302:1 · "Hodgkin lymphoma" is not a recognised heading for this article type.

"Plasma cell neoplasms and other diseases with paraproteins"

Line 307:1 · "Plasma cell neoplasms and other diseases with paraproteins" is not a recognised heading for this article type.

"T-cell and NK-cell lymphoid proliferations and lymphomas"

Line 342:1 · "T-cell and NK-cell lymphoid proliferations and lymphomas" is not a recognised heading for this article type.

"Tumour-like lesions with T-cell predominance"

Line 343:1 · "Tumour-like lesions with T-cell predominance" is not a recognised heading for this article type.

"Precursor T-cell neoplasms"

Line 349:1 · "Precursor T-cell neoplasms" is not a recognised heading for this article type.

"Mature T-cell and NK-cell neoplasms"

Line 354:1 · "Mature T-cell and NK-cell neoplasms" is not a recognised heading for this article type.

"Stroma-derived neoplasms of lymphoid tissues"

Line 426:1 · "Stroma-derived neoplasms of lymphoid tissues" is not a recognised heading for this article type.

"Mesenchymal dendritic cell neoplasms"

Line 427:1 · "Mesenchymal dendritic cell neoplasms" is not a recognised heading for this article type.

"Myofibroblastic tumours"

Line 433:1 · "Myofibroblastic tumours" is not a recognised heading for this article type.

"Spleen-specific vascular-stromal tumours"

Line 435:1 · "Spleen-specific vascular-stromal tumours" is not a recognised heading for this article type.

"Genetic tumour syndromes"

Line 441:1 · "Genetic tumour syndromes" is not a recognised heading for this article type.

"Changes from prior versions"

Line 448:1 · "Changes from prior versions" is not a recognised heading for this article type.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0